|
CA2261619C
(en)
*
|
1996-07-26 |
2006-05-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
PT1256584E
(pt)
*
|
1997-07-25 |
2004-12-31 |
Gilead Sciences Inc |
Processo para a preparacao de adefovir-dipivoxil
|
|
EP1243590B1
(en)
*
|
1997-07-25 |
2005-02-09 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
|
ATE288914T1
(de)
*
|
1997-07-25 |
2005-02-15 |
Gilead Sciences Inc |
Nukleotid-analog zusamensetzung und synthese verfahren
|
|
JP2002518452A
(ja)
*
|
1998-06-24 |
2002-06-25 |
エモリ ユニバーシティ |
Ｈｉｖの治療薬物の製造のための他の抗ｈｉｖ薬と組み合わせた３’−アジド−２’，３’−ジデオキシウリジンの使用
|
|
AU2001282941C1
(en)
*
|
2000-07-21 |
2016-12-22 |
Gilead Sciences, Inc. |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
|
|
IL164491A0
(en)
|
2002-04-26 |
2005-12-18 |
Gilead Sciences Inc |
Non nucleoside reverse transcriptase inhibitors
|
|
PL408254A1
(pl)
|
2003-01-14 |
2014-07-21 |
Gilead Sciences Inc. |
Kompozycje i i sposoby wykorzystywane w skojarzonej terapii przeciwwirusowej
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
MXPA05011296A
(es)
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de la cinasa.
|
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
AU2004247305B2
(en)
|
2003-06-16 |
2010-02-18 |
Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic |
Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
|
|
WO2005042772A1
(en)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
WO2005063258A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US7432272B2
(en)
|
2003-12-22 |
2008-10-07 |
Gilead Sciences, Inc. |
Antiviral analogs
|
|
EP1778251B1
(en)
|
2004-07-27 |
2011-04-13 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates as anti hiv agents
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
WO2006133632A1
(fr)
*
|
2005-06-13 |
2006-12-21 |
Brightgene Bio-Medical Technology Co., Ltd. |
Promedicament analogue nucleotidique et sa preparation
|
|
CA2683316A1
(en)
|
2007-04-13 |
2009-02-19 |
Southern Research Institute |
Anti-angiogenic agents and methods of use
|
|
CA2687647A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Ultimorphix Technologies B.V. |
Tenofovir disoproxil hemi-fumaric acid co-crystal
|
|
WO2009064174A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
|
EP2291386B1
(en)
*
|
2008-04-25 |
2016-01-13 |
Cipla Limited |
Crystalline form of tenofovir disoproxil and a process for its preparation
|
|
UA103329C2
(ru)
|
2008-07-08 |
2013-10-10 |
Гилиад Сайенсиз, Инк. |
Соли соединений-ингибиторов вич
|
|
CN102093422B
(zh)
*
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
|
NZ615939A
(en)
*
|
2011-05-10 |
2015-04-24 |
Aratana Therapeutics Nv |
Compounds for use in the treatment of feline retroviral infections
|
|
WO2013025788A1
(en)
|
2011-08-16 |
2013-02-21 |
Gilead Sciences, Inc. |
Tenofovir alafenamide hemifumarate
|
|
CN103626802A
(zh)
*
|
2012-08-23 |
2014-03-12 |
重庆药友制药有限责任公司 |
一种制备替诺福韦的新方法
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
KR102186030B1
(ko)
|
2012-10-29 |
2020-12-03 |
시플라 리미티드 |
항 바이러스성 포스포네이트 유사체 및 이의 제조를 위한 방법
|
|
EP2860185A1
(en)
|
2013-10-09 |
2015-04-15 |
Zentiva, k.s. |
An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
|
|
PT2860184T
(pt)
|
2013-10-09 |
2018-11-20 |
Zentiva Ks |
Sal de di-hidrogenofosfato de tenofovir disoproxil
|
|
TWI660965B
(zh)
*
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
|
PL3661937T3
(pl)
|
2017-08-01 |
2021-12-20 |
Gilead Sciences, Inc. |
Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
|
|
CN107805202A
(zh)
*
|
2017-12-01 |
2018-03-16 |
内蒙古圣氏化学股份有限公司 |
一种氯甲基异丙基碳酸酯连续化反应装置及方法
|